Magnesita reported its 1Q16 results with consolidated revenues down 9% year-over-year to $247 million. Refractory solutions sales declined across all regions, with revenues down 15% to $713 million for the last twelve months. Gross margins increased to 34.1% in 1Q16 from 26.2% in 4Q15 due to cost reduction initiatives. EBITDA excluding other income/expenses was $49 million in 1Q16, up 70% from 4Q15. Working capital as a percentage of annualized quarterly sales was 27.2% in 1Q16.